Diabetes & Metabolism Journal

Original Articles

Obesity and Metabolic Syndrome
Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus: Ji Hye Huh, Sung Gyun Ahn, Young In Kim, Taehwa Go, Ki-Chul Sung, Jae Hyuk Choi, Kwang Kon Koh, Jang Young Kim; Diabetes Metab J. 2019;43(4):530-538. Published online February 20, 2019; DOI: https://doi.org/10.4093/dmj.2018.0111

5,094 View
55 Download
20 Web of Science
23 Crossref

Background

Metabolic syndrome (MetS) is a known predictor of diabetes mellitus (DM), but whether longitudinal changes in MetS status modify the risk for DM remains unclear. We investigated whether changes in MetS status over 2 years modify the 10-year risk of incident DM.

Methods

We analyzed data from 7,317 participants aged 40 to 70 years without DM at baseline, who took part in 2001 to 2011 Korean Genome Epidemiology Study. Subjects were categorized into four groups based on repeated longitudinal assessment of MetS status over 2 years: non-MetS, resolved MetS, incident MetS, and persistent MetS. The hazard ratio (HR) of new-onset DM during 10 years was calculated in each group using Cox models.

Results

During the 10-year follow-up, 1,099 participants (15.0%) developed DM. Compared to the non-MetS group, the fully adjusted HRs for new-onset DM were 1.28 (95% confidence interval [CI], 0.92 to 1.79) in the resolved MetS group, 1.75 (95% CI, 1.30 to 2.37) in the incident MetS group, and 1.98 (95% CI, 1.50 to 2.61) in the persistent MetS group (P for trend <0.001). The risk of DM in subjects with resolved MetS was significantly attenuated compared to those with persistent MetS over 2 years. In addition, the adjusted HR for 10-year developing DM gradually increased as the number of MetS components increased 2 years later.

Conclusion

We found that discrete longitudinal changes pattern in MetS status over 2 years associated with 10-year risk of DM. These findings suggest that monitoring change of MetS status and controlling it in individuals may be important for risk prediction of DM.

Citations

Citations to this article as recorded by

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid I. Almarzooq, Cheryl A.M. Anderson, Pankaj Arora, Christy L. Avery, Carissa M. Baker-Smith, Bethany Barone Gibbs, Andrea Z. Beaton, Amelia K. Boehme, Yvonne Commodore-Mensah, Maria E. Currie, Mitchell S.V. Elkind, Kelly
Circulation.2024;[Epub] CrossRef
Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults
Hadas Ben-Assayag, Rafael Y. Brzezinski, Shlomo Berliner, David Zeltser, Itzhak Shapira, Ori Rogowski, Sharon Toker, Roy Eldor, Shani Shenhar-Tsarfaty
Cardiovascular Diabetology.2023;[Epub] CrossRef
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid I. Almarzooq, Cheryl A.M. Anderson, Pankaj Arora, Christy L. Avery, Carissa M. Baker-Smith, Andrea Z. Beaton, Amelia K. Boehme, Alfred E. Buxton, Yvonne Commodore-Mensah, Mitchell S.V. Elkind, Kelly R. Evenson, Chete Ez
Circulation.2023;[Epub] CrossRef
The Unique Role of Self-Rated Health in Metabolic Syndrome and its Diagnostic Cardiometabolic Abnormalities: An Analysis of Population-Based Data
K. Umeh, S. Adaji, L. Graham
Journal of Medical Psychology.2023; 25(1): 7. CrossRef
Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study
Farzad Hadaegh, Amir Abdi, Karim Kohansal, Parto Hadaegh, Fereidoun Azizi, Maryam Tohidi
Frontiers in Endocrinology.2023;[Epub] CrossRef
Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study
Yu Ho Lee, Sang Heon Song, Seung Hwan Song, Ho Sik Shin, Jaeseok Yang, Myoung Soo Kim, Hyeon Seok Hwang, Curie Ahn, Jaeseok Yang, Jin Min Kong, Oh Jung Kwon, Deok Gie Kim, Cheol-Woong Jung, Yeong Hoon Kim, Joong Kyung Kim, Chan-Duck Kim, Ji Won Min, Sung
Nephrology Dialysis Transplantation.2023; 38(12): 2743. CrossRef
Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes
Atieh Amouzegar, Mohammadjavad Honarvar, Safdar Masoumi, Davood Khalili, Fereidoun Azizi, Ladan Mehran
Journal of Translational Medicine.2023;[Epub] CrossRef
Differential association of metabolic syndrome and low-density lipoprotein cholesterol with incident cardiovascular disease according to sex among Koreans: a national population-based study
Su Yong Kim, Tae-Hwa Go, Jun Hyeok Lee, Jin Sil Moon, Dae Ryong Kang, Se Jin Bae, Se-Eun Kim, Sang Jun Lee, Dong-Hyuk Cho, Young Jun Park, Young Jin Youn, Jang Young Kim, Sung Gyun Ahn
European Journal of Preventive Cardiology.2022; 28(18): 2021. CrossRef
The efficacy and safety of Dendropanax morbifera leaf extract on the metabolic syndrome: a 12-week, placebo controlled, double blind, and randomized controlled trial
Ji Eun Jun, You-Cheol Hwang, Kyu Jeung Ahn, Ho Yeon Chung, Se Young Choung, In-Kyung Jeong
Nutrition Research and Practice.2022; 16(1): 60. CrossRef
Stability and Transformation of Metabolic Syndrome in Adolescents: A Prospective Assessment in Relation to the Change of Cardiometabolic Risk Factors
Pei-Wen Wu, Yi-Wen Lai, Yu-Ting Chin, Sharon Tsai, Tun-Min Yang, Wei-Ting Lin, Chun-Ying Lee, Wei-Chung Tsai, Hsiao-Ling Huang, David W. Seal, Tsai-Hui Duh, Chien-Hung Lee
Nutrients.2022; 14(4): 744. CrossRef
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid I. Almarzooq, Alvaro Alonso, Andrea Z. Beaton, Marcio S. Bittencourt, Amelia K. Boehme, Alfred E. Buxton, April P. Carson, Yvonne Commodore-Mensah, Mitchell S.V. Elkind, Kelly R. Evenson, Chete Eze-Nliam, Jane F. Fergus
Circulation.2022;[Epub] CrossRef
Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
Journal of General Internal Medicine.2022; 37(16): 4153. CrossRef
Nonlinear association between changes in fasting plasma glucose and the incidence of diabetes in a nondiabetic Chinese cohort
Chenghu Huang, Chenhong Ren, Xiuping Xuan, Yi Luo, Caibi Peng
BMC Endocrine Disorders.2022;[Epub] CrossRef
The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS)
Pezhman Bagheri, Davood Khalil, Mozhgan Seif, Esmaeil Khedmati Morasae, Ehsan Bahramali, Fereidoun Azizi, Abbas Rezaianzadeh
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 99. CrossRef
Heart Disease and Stroke Statistics—2021 Update
Salim S. Virani, Alvaro Alonso, Hugo J. Aparicio, Emelia J. Benjamin, Marcio S. Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Susan Cheng, Francesca N. Delling, Mitchell S.V. Elkind, Kelly R. Evenson, Jane F. Ferguson, Deepak K
Circulation.2021;[Epub] CrossRef
The dynamics of metabolic syndrome development from its isolated components among Iranian adults: findings from 17 years of the Tehran lipid and glucose study (TLGS)
Davood Khalili, Pezhman Bagheri, Mozhgan Seif, Abbas Rezaianzadeh, Esmaeil Khedmati Morasae, Ehsan Bahramali, Fereidoun Azizi
Journal of Diabetes & Metabolic Disorders.2021; 20(1): 95. CrossRef
Metabolic Syndrome Fact Sheet 2021: Executive Report
Ji Hye Huh, Dae Ryong Kang, Jang Young Kim, Kwang Kon Koh
CardioMetabolic Syndrome Journal.2021; 1(2): 125. CrossRef
The Incidence of Metabolic Syndrome and the Valid Blood Pressure Cutoff Value for Predicting Metabolic Syndrome Within the Normal Blood Pressure Range in the Population Over 40 Years Old in Guiyang, China
Li Ma, Hong Li, Huijun Zhuang, Qiao Zhang, Nianchun Peng, Ying Hu, Na Han, Yuxing Yang, Lixin Shi
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2973. CrossRef
Metabolic Syndrome Severity Score for Predicting Cardiovascular Events: A Nationwide Population-Based Study from Korea
Yo Nam Jang, Jun Hyeok Lee, Jin Sil Moon, Dae Ryong Kang, Seong Yong Park, Jerim Cho, Jang-Young Kim, Ji Hye Huh
Diabetes & Metabolism Journal.2021; 45(4): 569. CrossRef
Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study
You-Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han, Hye Jin Yoo
Cardiovascular Diabetology.2020;[Epub] CrossRef
Effects of tea consumption on metabolic syndrome: A systematic review and meta‐analysis of randomized clinical trials
Wei Liu, Chunpeng Wan, Yingjie Huang, Mingxi Li
Phytotherapy Research.2020; 34(11): 2857. CrossRef
Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study
Eun Young Lee, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
Cardiovascular Diabetology.2020;[Epub] CrossRef
Changes in Metabolic Profile Over Time: Impact on the Risk of Diabetes
Yunjung Cho, Seung-Hwan Lee
Diabetes & Metabolism Journal.2019; 43(4): 407. CrossRef

Association Between Impaired Vascular Endothelial Function and High Sensitivity C-reactive Protein, a Chronic Inflammatory Marker, in Patients with Type 2 Diabetes Mellitus.: Jang Yel Shin, Mi Young Lee, Jang Hyun Koh, Jang Young Kim, Young Goo Shin, Choon Hee Chung; Korean Diabetes J. 2005;29(5):469-478. Published online September 1, 2005

896 View
19 Download

Abstract PDF: BACKGOUND: Eighty percents of diabetes-related mortalities are due to atherosclerotic vascular complications. The accelerated atherosclerosis in type 2 diabetic patients is partly due to the increased incidences of cardiovascular risk factors, such as hypertension, obesity, dyslipidemia, insulin resistance and oxidative stress. Endothelial dysfunction is known as an early marker of cardiovascular disease and a predictor of cardiovascular events. The flow mediated dilation (FMD) of the brachial artery has been documented as being reduced in type 2 diabetic patients. Inflammatory markers, such as C-reactive protein(CRP) and interleukin-6(IL-6), are associated with the risk of cardiovascular disease. Endothelial dysfunction has a direct correlation with the levels of CRP, which are elevated in patients with diabetes compared with non-diabetic subjects. In this study, the FMD in diabetic and non-diabetic subjects were compared, and the association of cardiovascular risk factors and endothelial function examined in type 2 diabetic patients. METHODS: 57 consecutive diabetic subjects and 29 non-diabetic subjects, aged 35 to 69(54.0+/-1.0 years), without proven macrovascular complications, were enrolled in this study. Cardiovascular risk factors, such as body weight, height, waist and hip circumference, fasting plasma glucose and insulin levels, lipid profiles, inflammatory and coagulation markers were measured. The FMD of the brachial artery and the intima-media thickness(IMT) of the carotid artery were determined using high-resolution B-mode ultrasound. RESULTS: The FMD values were significantly lower in the diabetic compared with the non-diabetic subjects(7.6+/-0.2% vs. 8.9+/-0.4%, P=0.004). The homocysteine levels were significantly higher in the diabetic than non-diabetic subjects(12.4+/-0.4micromol/L vs. 9.5+/-0.6micromol/L, P<0.0001). In diabetic subjects, the FMD was shown to be significantly negatively correlated with high sensitivity C-reactive protein(hsCRP)(P=0.006), fibrinogen(P=0.024) and homocysteine (P=0.038). A multiple regression analysis, after adjusted for age, sex, body mass index(BMI), hypertension, and smoking, showed that hsCRP(beta=-0.424, P=0.002) and fibrinogen(beta=-0.324, P=0.025) had significant inverse association with the FMD in diabetic subjects. CONCLUSION: Diabetic subjects have an impaired endothelial function compared with the non-diabetic subjects, and the vascular endothelial function has a significant negative correlation with hsCRP and fibrinogen. These findings suggest that hsCRP might be an independent predictor of endothelial dysfunction and atherosclerosis, and chronic inflammation might play a pivotal role in the impairment of the endothelial function in diabetic patients.

First
Prev
Page of 1
Next
Last

Search